APR-246/PRIMA-1MET inhibits thioredoxin reductase 1 and converts the enzyme to a dedicated NADPH oxidase
出版年份 2013 全文链接
标题
APR-246/PRIMA-1MET inhibits thioredoxin reductase 1 and converts the enzyme to a dedicated NADPH oxidase
作者
关键词
-
出版物
Cell Death & Disease
Volume 4, Issue 10, Pages e881-e881
出版商
Springer Nature
发表日期
2013-10-24
DOI
10.1038/cddis.2013.417
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- APR-246/PRIMA-1MET rescues epidermal differentiation in skin keratinocytes derived from EEC syndrome patients with p63 mutations
- (2013) J. Shen et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Thioredoxin Reductase Inhibition Elicits Nrf2-Mediated Responses in Clara Cells: Implications for Oxidant-Induced Lung Injury
- (2012) Morgan L. Locy et al. ANTIOXIDANTS & REDOX SIGNALING
- Allele-Specific p53 Mutant Reactivation
- (2012) Xin Yu et al. CANCER CELL
- Targeting p53 in Vivo: A First-in-Human Study With p53-Targeting Compound APR-246 in Refractory Hematologic Malignancies and Prostate Cancer
- (2012) Sören Lehmann et al. JOURNAL OF CLINICAL ONCOLOGY
- Pyrroloquinoline quinone modulates the kinetic parameters of the mammalian selenoprotein thioredoxin reductase 1 and is an inhibitor of glutathione reductase
- (2011) Jianqiang Xu et al. BIOCHEMICAL PHARMACOLOGY
- Mutant p53 rescue and modulation of p53 redox state
- (2011) Vladimir J.N. Bykov et al. CELL CYCLE
- p53-dependent inhibition of TrxR1 contributes to the tumor-specific induction of apoptosis by RITA
- (2011) Elisabeth Hedström et al. CELL CYCLE
- Hepatocyte DNA replication in growing liver requires either glutathione or a single allele of txnrd1
- (2011) Justin R. Prigge et al. FREE RADICAL BIOLOGY AND MEDICINE
- Loss of Thioredoxin Reductase 1 Renders Tumors Highly Susceptible to Pharmacologic Glutathione Deprivation
- (2010) P. K. Mandal et al. CANCER RESEARCH
- Selenoproteins—What unique properties can arise with selenocysteine in place of cysteine?
- (2010) Elias S.J. Arnér EXPERIMENTAL CELL RESEARCH
- PRIMA-1MET/APR-246 targets mutant forms of p53 family members p63 and p73
- (2010) N Rökaeus et al. ONCOGENE
- Focus on mammalian thioredoxin reductases — Important selenoproteins with versatile functions
- (2009) Elias S.J. Arnér BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS
- PRIMA-1 Reactivates Mutant p53 by Covalent Binding to the Core Domain
- (2009) Jeremy M.R. Lambert et al. CANCER CELL
- High levels of thioredoxin reductase 1 modulate drug-specific cytotoxic efficacy
- (2009) Sofi E. Eriksson et al. FREE RADICAL BIOLOGY AND MEDICINE
- Cytoplasmic functions of the tumour suppressor p53
- (2009) Douglas R. Green et al. NATURE
- Cytoprotective Nrf2 Pathway Is Induced In Chronically Txnrd 1-Deficient Hepatocytes
- (2009) Elena S. Suvorova et al. PLoS One
- Thioredoxin system inhibitors as mediators of apoptosis for cancer therapy
- (2008) Kathryn F. Tonissen et al. MOLECULAR NUTRITION & FOOD RESEARCH
- Mutant p53 targeting by the low molecular weight compound STIMA-1
- (2008) Nicole Zache et al. Molecular Oncology
- Cell Death by SecTRAPs: Thioredoxin Reductase as a Prooxidant Killer of Cells
- (2008) Karin Anestål et al. PLoS One
- Targeted rescue of a destabilized mutant of p53 by an in silico screened drug
- (2008) F. M. Boeckler et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started